Skip to content

Dr. THYWISSEN

Active Private limited companyfounded 2000active for 26 yearsPampertstraat 44, 3590 DiepenbeekKBO/BCE: BE 0472.413.358 #4 company by equity in Diepenbeek, Health and social work sector

Lifetime

20 annual accounts with figures on one time axis, 26 filings since 2000
peak of €435,464 in 2019
€190,523▼ 48.8%
lowest -€16,104 in 2010
€237,688▼ 44.2%
peak of €2.2m in 2025
€2.2m▲ 12.4%
€51,510▲ 21.9%
Board1 name since 2012
1 director
Documentsfilings and deeds
03-07-202628 days before the deadline
2025micro format
Gross margin from €372,385 to €190,523Result from €425,995 to €237,688Equity from €1.9m to €2.2mDebts from €42,246 to €51,510Cash from €144,354 to €1.3m

Key points

from the 2025 annual accounts

Equity

€2.2m ▲ 12.4%

Dr. THYWISSEN has made a profit without a break since 2012.

Result

€237,688 ▼ 44.2%
€426,0002024€238,0002025

The result fell in 2025 from €425,995 to €237,688.

Turnover

≈ €350,000 estimated

The micro format states no turnover.

Investments

€37,168 1.9 times depreciation
202120222025

Green is investment, beige is depreciation.

Filings

26 annual accounts since 2000
AprilJune31 JulyOctober200020102020

Four of the last ten came late. The 2016 accounts came in latest, 66 days after the end of the period.

Position in the sector

97.7%

Higher solvency than 95% of companies in human health. The sector median is 63.1%, over 21,373 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,149 companies had the same profile as Dr. THYWISSEN has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,149 companies, not a prediction for Dr. THYWISSEN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 400 sharesdeed of 20-01-2014
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0472413358
reappointed as director Asset distribution: €68,000 · General meeting of 29-08-2022 · Gazette deed
Capital increase · Amendment of the articles The capital rose from €20,000 to €60,000, with 400 new shares · The capital rose from €60,000 to €68,500 · Contribution by (€40,000, 400 shares) · General meeting of 18-12-2013 · Gazette deed
reappointed as manager General meeting of 12-07-2012 · Gazette deed
All 41 events

Comparable companies

same main activity, similar in size and age
Company
Dr. THYWISSEN Diepenbeek €2.2m €190,523 97.7% -
DENEUCARE Ottignies-Louvain-la-Neuve €2.1m €186,593 59.9% -
SOCIETE MEDICALE DU DOCTEUR CUVELIER PIERRE Gerpinnes €2.2m €198,360 83.3% -
Dr KEMNITZ SPRL Voeren €2.0m €232,082 60.6% -
KARAR MEDICAL Brussels €2.2m €206,785 4.9% -
DR. KOEN MELIS Knokke-Heist €1.8m €187,851 83.4% -
DR. GEERT PAGE Poperinge €1.9m €173,292 34.9% -

These companies have the same main activity as Dr. THYWISSEN: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.8m and €2.2m, founded between 2000 and 2005.

Official details

Source: KBO
Status
Active since 17-07-2000Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.190.635.1323590 Diepenbeek, since 01-04-2000
Financial year end
31 December
Peppol
Reachable since 03-03-2025
Company details

Annual accounts 2025

€2.2m▲ 12.6%
Filing
Filed on 03-07-2026, 28 days before the end of the filing period
Financials

Insights on Dr. THYWISSEN

Dr. THYWISSEN files the micro format. That format states no turnover. The gross margin rose from €61,528 in 2006 to €190,523 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. THYWISSEN

What is the company number of Dr. THYWISSEN?
The company number of Dr. THYWISSEN is 0472.413.358. The VAT number is the same number with BE in front: BE 0472.413.358.
Where is Dr. THYWISSEN based?
The registered office is at Pampertstraat 44, 3590 Diepenbeek.Company details
What does Dr. THYWISSEN do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. THYWISSEN?
Dr. THYWISSEN is a private limited company (BV).
When was Dr. THYWISSEN founded?
Dr. THYWISSEN was founded on 17-07-2000.
Is Dr. THYWISSEN still active?
Yes, Dr. THYWISSEN is an active enterprise in the KBO register.
What is the turnover of Dr. THYWISSEN?
The turnover in financial year 2025 is about €350,000. This figure is estimated from the gross margin of €190,523 and 40 comparable companies (NACE 86220). It probably lies between €300,000 and €470,000.Financials
Is Dr. THYWISSEN profitable?
In financial year 2025, Dr. THYWISSEN made a profit of €237,688.
Where can I find the annual accounts of Dr. THYWISSEN?
Dr. THYWISSEN filed 26 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. THYWISSEN due?
Dr. THYWISSEN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.